Logo

Vanderbilt Researchers to Use FGT s Data Management System to Study Genetics of Drug Side Effects

Jan 18, 2005

NEW YORK, Jan. 18 (GenomeWeb News) - First Genetic Trust will provide the VanderbiltUniversityMedicalCenterwith its genetic data management system to further study the genetics of drug side effects, the two organizations said yesterday.

 

Vanderbilt researchers plans to use FGT's web-based EnTrust study-management system to expand their research on the genetics of drug-induced prolonged QT, a side effect for many different drug classes.

 

The system allows the VUMC researchers to enroll patients referred by other clinicians electronically. FGT's platform will be used to manage online informed consent, samples, clinical data, and genetic data. First Genetic Trust is headquartered in Chicago.

 

Financial terms of the agreement were not disclosed.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.